Maximon boosts its leadership with Harvard and Swiss trained excellence.
Dr Elisabeth Roider, who is dedicated to bringing the field of longevity to the next level, has joined the Swiss-based longevity company builder Maximon as Partner and Chief Scientific and Medical Officer.
Longevity.Technology: Elisabeth Roider, MD, PhD, MBA, is a Harvard- and Swiss-trained, internationally renowned physician scientist. As a physician-scientist, she works at the University Hospital of Basel and the Harvard Medical School. Her work has resulted in various high-impact publications, patents and awards.
Driven by the mission to identify and solve the most relevant medical and public health problems, Roider joins Maximon as a Partner & Chief Scientific and Medical Officer.
“Longevity science is exciting but for multiple reasons highly under investigated,” she says. With the help of Maximon and private investors, I am eager to drive innovation to the next level to see what the distant future will look like.”
READ MORE: Launchpad for longevity investment and networking
Roider’s aim is to support scientists and physicians in transforming true innovation into solid solutions and products, helping patients and consumers to achieve better, healthier – and finally, longer – lives.
She adds: “I love life, I love science, I love people. Together with Maximon’s outstanding team I am excited to allow more people to enjoy a long, healthy, and fulfilled life.”